Oriol Dols-Icardo

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies.

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.

Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion.

Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.

Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.

Assessing the role of TUBA4A gene in frontotemporal degeneration.

Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.

Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the expansion mutation.

PRRX1 Rs3903239 polymorphism and atrial fibrillation in a Greek population.

Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.

CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.

HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.

Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy.

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders.

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

Genetic architecture of neurodegenerative dementias.

Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis.

Developmental Dynamic Dysphasia: Are Bilateral Brain Abnormalities a Signature of Inefficient Neural Plasticity?

Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration.

Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis.

Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.

, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.

Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia.

Heterozygous APOE Christchurch in familial Alzheimer's disease without mutations in other Mendelian genes.

Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration.

Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat.

Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies.

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.

Myelin loss in C9orf72 hexanucleotide expansion carriers.

Network Tau spreading is vulnerable to the expression gradients of and glutamatergic-related genes.